New Fiber-Optic tech aims to make liver shunt surgery safer
NCT ID NCT07470515
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a fiber-optic navigation system that gives doctors a 3D view during a procedure called TIPS, which treats complications of liver cirrhosis like fluid buildup or bleeding. About 30 patients will be enrolled to see if the device reduces the number of needle sticks, radiation exposure, and procedure time. The goal is to make this common liver procedure safer and more efficient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fiber-optic navigation system (device)
- What this could lead to
- If successful, this device could make TIPS procedures safer and faster by reducing the number of needle sticks and radiation exposure for patients with liver complications.
- What could go wrong
- This is a small pilot study with only 30 participants, so results may not apply to all patients. The device may not improve outcomes or could have unforeseen technical issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Innsbruck
Innsbruck, Tyrol, 6020, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can extra doses of an old drug reverse liver scarring?
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test